INS and diabetes mellitus: Across four primary studies of adults with insulin-treated diabetes, the Diabetes Fear of Injecting and Self-testing Questionnaire (D-FISQ) yielded estimates of needle fear between 0.2–43% (Table 2, section 1c) [34, 42, 45, 46].